Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Exchange Rate Effect (2021 - 2025)

Historic Exchange Rate Effect for Veracyte (VCYT) over the last 5 years, with Q3 2025 value amounting to $60000.0.

  • Veracyte's Exchange Rate Effect fell 5890.41% to $60000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $306000.0, marking a year-over-year increase of 1167.88%. This contributed to the annual value of -$424000.0 for FY2024, which is 36012.27% down from last year.
  • Veracyte's Exchange Rate Effect amounted to $60000.0 in Q3 2025, which was down 5890.41% from $573000.0 recorded in Q2 2025.
  • Veracyte's 5-year Exchange Rate Effect high stood at $732000.0 for Q4 2022, and its period low was -$1.8 million during Q2 2021.
  • For the 5-year period, Veracyte's Exchange Rate Effect averaged around -$92222.2, with its median value being $21500.0 (2023).
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first plummeted by 77142.86% in 2024, then surged by 103934.43% in 2025.
  • Veracyte's Exchange Rate Effect (Quarter) stood at $164000.0 in 2021, then skyrocketed by 346.34% to $732000.0 in 2022, then plummeted by 59.43% to $297000.0 in 2023, then tumbled by 235.02% to -$401000.0 in 2024, then skyrocketed by 114.96% to $60000.0 in 2025.
  • Its last three reported values are $60000.0 in Q3 2025, $573000.0 for Q2 2025, and $74000.0 during Q1 2025.